Atrium Therapeutics, Inc. (RNA) has 12 identified peers for comparison in the Healthcare sector. Peers include AKRO, ARVN, BCEL, BDTX, CERE, CGEM and others.
RNA has a market capitalization of $217.52M, compared to an average peer market cap of $2.11B. RNA is notably smaller than its average peer.
